During the last session, Atyr Pharma Inc (NASDAQ:ATYR)’s traded shares were 0.45 million, with the beta value of the company hitting 1.09. At the end of the trading day, the stock’s price was $3.59, reflecting an intraday gain of 0.84% or $0.03. The 52-week high for the ATYR share is $4.22, that puts it down -17.55 from that peak though still a striking 60.45% gain since the share price plummeted to a 52-week low of $1.42. The company’s market capitalization is $301.35M, and the average intraday trading volume over the past 10 days was 0.87 million shares, and the average trade volume was 881.90K shares over the past three months.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Atyr Pharma Inc (ATYR) registered a 0.84% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.84% in intraday trading to $3.59, hitting a weekly high. The stock’s 5-day price performance is -4.27%, and it has moved by 7.16% in 30 days. Based on these gigs, the overall price performance for the year is 133.12%. The short interest in Atyr Pharma Inc (NASDAQ:ATYR) is 3.65 million shares and it means that shorts have 4.37 day(s) to cover.
Atyr Pharma Inc (ATYR) estimates and forecasts
Statistics show that Atyr Pharma Inc has underperformed its competitors in share price, compared to the industry in which it operates. Atyr Pharma Inc (ATYR) shares have gone up 86.01% during the last six months, with a year-to-date growth rate less than the industry average at 3.19% against 16.50. In the rating firms’ projections, revenue will decrease -56.70% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 43.36%. While earnings are projected to return 2.84% in 2025, the next five years will return 13.72% per annum.
ATYR Dividends
Atyr Pharma Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Atyr Pharma Inc (ATYR) shares are Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund . Data provided on Oct 31, 2024 indicates that Federated Hermes Kaufmann Fund owns about 7.85 shares. This amounts to just over 9.35 percent of the company’s overall shares, with a $28.18 million market value. The same data shows that the other fund manager holds slightly less at 6.62, or about 7.89% of the stock, which is worth about $23.77 million.
